Evidence map›Paper›PMID 34952944›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2022

Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon response.

Elizabeth Y Li, Jason Xu, Nya D Nelson, David T Teachey, Kai Tan, Neil Romberg, Ed Behrens, Vinodh Pillai

Abstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Elizabeth Y Li *Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Jason Xu *Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Nya D NelsonDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
David T TeacheyDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kai TanDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Neil RombergDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Ed BehrensDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Vinodh PillaiPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. pillaiv1@chop.edu.ORCID http://orcid.org/0000-0001-7126-6226
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kikuchi-Fujimoto disease (KFD) is a reactive lymphadenitis of unclear etiology. To understand the pathogenesis of KFD, we performed targeted RNA sequencing of a well-characterized cohort of 15 KFD specimens with 9 non-KFD lymphadenitis controls. Two thousand and three autoimmunity-related genes were evaluated from archived formalin-fixed paraffin-embedded lymph node tissue and analyzed by a bioinformatics approach. Differential expression analysis of KFD cases compared to controls revealed 44 significantly upregulated genes in KFD. Sixty-eight percent of these genes were associated with the type I interferon (IFN) response pathway. Key component of the pathway including nucleic acid sensors, IFN regulatory factors, IFN-induced antiviral proteins, IFN transcription factors, IFN-stimulated genes, and IFN-induced cytokines were significantly upregulated. Unbiased gene expression pathway analysis revealed enrichment of IFN signaling and antiviral pathways in KFD. Protein-protein interaction analysis and a molecular complex detection algorithm identified a densely interacting 15-gene module of type I IFN pathway genes. Apoptosis regulator IFI6 was identified as a key seed gene. Transcription factor target analysis identified enrichment of IFN-response elements and IFN-response factors. T-cell-associated genes were upregulated while myeloid and B-cell-associated genes were downregulated in KFD. CD123+ plasmacytoid dendritic cells (PDCs) and activated T cells were noted in KFD. In conclusion, KFD is mediated by an aberrant type I interferon response that is likely driven by PDCs and T cells.

Indexed as

Histiocytic Necrotizing LymphadenitisInterferon Type ILymphadenitisAntiviral AgentsHumansLymph NodesAntiviral AgentsInterferon Type I

Identifiers

PMID34952944
OpenAlexW4200517016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.